Juan Roura - Grifols SA Vice President of Production, Executive Director

GRFS Stock  USD 6.65  0.17  2.62%   

President

Mr. Juan Ignacio Twose Roura serves as Member of the Advisory Committee of Grifols, S.A. since 2016. Moreover, he was Chief Executive Officer and Board Member of Arrahona Optimus SL, as well as Board Member of Biomat USA Inc, Grifols Inc, Instituto Grifols SA and Plasmacare Inc and Administrator of Grifols Engineering SA. He holds a Bachelors degree in Industrial Engineering from Escola Tecnica Superior dEnginyeria Industrial de Barcelona. since 2016.
Tenure 8 years
Address Avinguda de la Generalitat, 152, Barcelona, Spain, 08174
Phone34 935 712 200
Webhttps://www.grifols.com

Grifols SA Management Efficiency

The company has return on total asset (ROA) of 0.0214 % which means that it generated a profit of $0.0214 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of 0.022 %, meaning that it created $0.022 on every $100 dollars invested by stockholders. Grifols SA's management efficiency ratios could be used to measure how well Grifols SA manages its routine affairs as well as how well it operates its assets and liabilities. Return On Capital Employed is likely to drop to 0.04 in 2024. Return On Assets is likely to drop to 0 in 2024. At this time, Grifols SA's Asset Turnover is comparatively stable compared to the past year.
The company currently holds 10.12 B in liabilities with Debt to Equity (D/E) ratio of 1.14, which is about average as compared to similar companies. Grifols SA ADR has a current ratio of 2.63, suggesting that it is liquid enough and is able to pay its financial obligations when due. Debt can assist Grifols SA until it has trouble settling it off, either with new capital or with free cash flow. So, Grifols SA's shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like Grifols SA ADR sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for Grifols to invest in growth at high rates of return. When we think about Grifols SA's use of debt, we should always consider it together with cash and equity.

Similar Executives

Showing other executives

PRESIDENT Age

Thomas DesRosierSeres Therapeutics
63
Craig PhilipsKineta Inc
63
Henrik AncherJensenAgilent Technologies
59
Rodney GonsalvesAgilent Technologies
58
Jacob ThaysenAgilent Technologies
49
Wael HashadSeres Therapeutics
N/A
Samraat RahaAgilent Technologies
51
Eilon AsculaiMediwound
N/A
Bruce CFAEquillium
58
Dominique GrauAgilent Technologies
65
Alicia RodriguezAgilent Technologies
N/A
Robert McMahonAgilent Technologies
55
Michele TrucksisSeres Therapeutics
64
Bruce SteelEquillium
50
Marcus ChapmanSeres Therapeutics
47
Michael TangAgilent Technologies
50
Patrick KaltenbachAgilent Technologies
53
Kevin HorganSeres Therapeutics
58
Mark DoakAgilent Technologies
63
Grifols, S.A. engages in the procurement, manufacture, preparation, and sale of therapeutic products, primarily hemoderivatives. The company was founded in 1940 and is headquartered in Barcelona, Spain. Grifols SA operates under Drug ManufacturersGeneral classification in the United States and is traded on NASDAQ Exchange. It employs 27584 people. Grifols SA ADR (GRFS) is traded on NASDAQ Exchange in USA. It is located in Avinguda de la Generalitat, 152, Barcelona, Spain, 08174 and employs 23,744 people. Grifols SA is listed under Biotechnology category by Fama And French industry classification.

Management Performance

Grifols SA ADR Leadership Team

Elected by the shareholders, the Grifols SA's board of directors comprises two types of representatives: Grifols SA inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Grifols. The board's role is to monitor Grifols SA's management team and ensure that shareholders' interests are well served. Grifols SA's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Grifols SA's outside directors are responsible for providing unbiased perspectives on the board's policies.
Antonio Pares, Director of Planning and Control
Alberto Roura, President Division
Carsten Schroeder, President Of The Diagnostic Division
Albert Roura, CEO of Laboratorios Grifols SA
Lafmin Morgan, President Of The Bioscience And Hospital Division
Juan Roura, Vice President of Production, Executive Director
Eva Tubau, Chief Scientific Officer
Anna Lluch, Independent Director
Carlos Fernandez, Deputy Industrial Vice President
Jose Gras, Director, Representative of Thorthol Holdings BV
Maria Llano, Chief Officer
Edgar Jannotta, Independent Director
Vicente Torre, Chief Officer
Mateo Humbert, Director of Human Resources
Montserrat Calvo, Chief Administrative Officer, Controller
Montserrat Llamas, Chief Officer
Ramon Roca, Vice-President of Marketing and Sales and Executive Director
Vctor Deu, CoCEO Director
David Bell, Vice President of Corporate Operations and Development of Grifols Inc and United States Subsidiaries
Victor Deu, Co-CEO, Executive Director
Luis Bobadilla, Independent Director
Inigo Mardones, Director
Thomas Glanzmann, CEO Chairman
Carina Lazaro, Independent Director
Joel Abelson, President of North America Commercial Division of Grifols Inc
Steven Mayer, Director
Javier Ribes, CEO of Instituto Grifols SA
Alfredo Guerra, CFO and Corporate VP
Raimon Roura, Non-Member Secretary of the Board
Victor Roura, Chairman, CEO and President and Member of Appointments and Remuneration Committee
Brett Ingersoll, Director
Shinji Wada, President of Plasma Centers of Grifols Inc
Tomas Gelabert, Director
Nuria Lapea, Risk Treasury
Sergio Adell, President Support
M Tubau, Corporate Affairs
Steven JD, Ex Chairman
Marla Salmon, Independent Director
Nuria Barnes, Non-Member Assistant Secretary of the Board
Gregory Rich, President of Grifols Inc and Subsidiaries in the US
Belen Morenes, Independent Director
Nuria Lapena, Director of Shareholder and Investor Relations

Grifols Stock Performance Indicators

The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is Grifols SA a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.

Grifols SA Investors Sentiment

The influence of Grifols SA's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Grifols. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Grifols SA's public news can be used to forecast risks associated with an investment in Grifols. The trend in average sentiment can be used to explain how an investor holding Grifols can time the market purely based on public headlines and social activities around Grifols SA ADR. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Grifols SA's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Grifols SA's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Grifols SA's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Grifols SA.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Grifols SA in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Grifols SA's short interest history, or implied volatility extrapolated from Grifols SA options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Grifols SA ADR is a strong investment it is important to analyze Grifols SA's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Grifols SA's future performance. For an informed investment choice regarding Grifols Stock, refer to the following important reports:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Grifols SA ADR. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in census.
Note that the Grifols SA ADR information on this page should be used as a complementary analysis to other Grifols SA's statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Fundamentals Comparison module to compare fundamentals across multiple equities to find investing opportunities.

Complementary Tools for Grifols Stock analysis

When running Grifols SA's price analysis, check to measure Grifols SA's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Grifols SA is operating at the current time. Most of Grifols SA's value examination focuses on studying past and present price action to predict the probability of Grifols SA's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Grifols SA's price. Additionally, you may evaluate how the addition of Grifols SA to your portfolios can decrease your overall portfolio volatility.
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Pattern Recognition
Use different Pattern Recognition models to time the market across multiple global exchanges
Equity Valuation
Check real value of public entities based on technical and fundamental data
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
Is Grifols SA's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Grifols SA. If investors know Grifols will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Grifols SA listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
1.787
Earnings Share
0.1
Revenue Per Share
4.849
Quarterly Revenue Growth
0.033
Return On Assets
0.0214
The market value of Grifols SA ADR is measured differently than its book value, which is the value of Grifols that is recorded on the company's balance sheet. Investors also form their own opinion of Grifols SA's value that differs from its market value or its book value, called intrinsic value, which is Grifols SA's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Grifols SA's market value can be influenced by many factors that don't directly affect Grifols SA's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Grifols SA's value and its price as these two are different measures arrived at by different means. Investors typically determine if Grifols SA is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Grifols SA's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.